The global cancer biologics market is anticipated to grow significantly at a CAGR of 5.3% over the forecast period (2022-2028). The rising prevalence of various types of cancer such as prostate, brain, lung, pancreatic, and others is the prominent factor the demand for cancer biologics is increasing which in turn driving the market growth. According to the American Cancer Society, 1 man in 41 will die of prostate cancer, and around 268490 new cases and 34,500 deaths have been reported in 2022, in the US from prostate cancer. Similarly, the American Cancer Society’s estimated around 62,210 people which includes(32,970 men and 29,240 women), will be diagnosed with pancreatic cancer. Around 49,830 people including 25,970 men and 23,860 women die due to pancreatic cancer in 2022, and pancreatic cancer accounts for about 3% of all major cancers and 7% of deaths in the US.
Browse the full report description of “Global Cancer Biologics Market Size, Share & Trends Analysis Report By Type (Monoclonal Antibodies, Vaccines, and Cell and Gene Therapy) By Distribution Channel (Hospitals, and Clinics) Forecast 2022-2028” at https://www.omrglobal.com/industry-reports/cancer-biologics-market
Moreover, in 2022, an estimated 700,000 people in the US are living with a primary brain tumor, and around 88,970 and more will be diagnosed in 2022. The brain tumor significantly impacts the quality of life, as it is treated to be the deadly one. The 8,970 people included 63,040 people who suffered from non-malignant brain tumors, and 25,930 suffered from malignant as per the National Brain Tumor Society. People across the world need cancer biologics treatment, which includes various tests, vaccines, and antitoxins, that are used as diagnostic, preventive, or therapeutic agents, to treat cancers. This is expected to surge the adoption of cancer biologics in cancer treatments with a positive impact on the market growth.
Market Coverage
Competitive Landscape-, Abbvie Inc., Amgen USA Inc., Bristol Myers Squibb Co., F.Hoffmann-La Roche Ltd., Glaxo Smith Kelvin., Atra Zeneca, Cue Biopharma., Eli Lilly and Co., Genmab A/S, Boehringer Ingelheim Pharmaceutical Inc., and others.
Key questions addressed by the report
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected region/segment
Global Cancer Biologics Market– Segmentation
By Type
By Distribution Channel
Global Cancer Biologics Market – Segmentation by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/cancer-biologics-market